Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
CN¥32.48 - CN¥56.98
Next Earnings Date
-
Next Earnings Date
-
Latest price
Market Cap | CN¥38.10B |
EV | CN¥38.24B |
Shares Outstanding | 719.23M |
Beta | 0.66 |
Analyst Rating | NOT_AVAILABLE |
Analyst Target Price | - |
P/E 2025E | - |
P/Revenue 2025E | - |
Revenue | 7.80% |
EPS | -6.70% |
Operating Cash Flow | 12.40% |
Free Cash Flow | 37.30% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | - |
ROE 2025E | - |
ROCE 2024 | 4.31% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
Cathay Biotech Inc.
688065
Sector
Basic Materials
Industry
Chemicals
CEO
Liu, Xiucai
Employees
1,803
Website
www.cathaybiotech.comIPO Date
2020-08-12
Headquarters
Lvzhou Ring Road, Building 11, Lane 396, Minhang District, Shanghai China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved